Home » Topics » BioWorld Science, Cardiovascular

BioWorld Science, Cardiovascular
RSS

Texas Biotechnology prepares new endothelin modulators

Jan. 15, 1998

AHC-52, a new dihydropyridine with cardioprotective effects

Jan. 14, 1998

Novel ET antagonists claimed by BASF

Jan. 14, 1998

New use approved for Lescol

Jan. 14, 1998

ProAmatine filed for approval in U.K.

Jan. 13, 1998

Lusofarmaco develops new angiotensin antagonists

Jan. 13, 1998

Efficacy established for ET antagonist in pulmonary hypertension

Jan. 13, 1998

Ketoacid ETA antagonists from Warner-Lambert

Jan. 12, 1998

NIH seeks CRADA partners or licensees for 12-LO metabolite

Jan. 9, 1998

NIH announces contemplation of licensing agreement for growth factors

Jan. 9, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...